Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT03270917Not ApplicableActive Not Recruiting

ORANGE SEGMENTS: Open Versus Laparoscopic Parenchymal Preserving Postero-Superior Liver Segment Resection

Role: collaborator

NCT01441856Not ApplicableCompleted

The ORANGE II PLUS - Trial: Open Versus Laparoscopic Hemihepatectomy

Role: collaborator

NCT04053816Phase 3Completed

Prevention of Dysrhythmias on the Cardiac Intensive Care Unit - Does Maintenance of High-normal Serum Potassium Levels Matter

Role: collaborator

NCT01795833Not ApplicableCompleted

Diabetes Prevention Using SMS Technology

Role: collaborator

NCT03265548Not ApplicableCompleted

Video Laryngoscopy in Newborn Babies V1

Role: collaborator

All 5 trials loaded